You searched for "lesion"
Verteporfin shortage: treatment options and outcomes in chronic non-resolving central serous chorioretinopathy
Half-dose photodynamic therapy (HD-PDT) with verteporfin has been the therapy of choice in non-resolving central serous chorioretinopathy lasting longer than four months. Since 2021, a worldwide shortage of verteporfin due to manufacturing issues prompted adjustments in treatment practices. This retrospective,...
Scleral fixation using Gore-Tex suture of a subluxated PCIOL
This was a retrospective single-centre study of patients who underwent lasso in-the-bag scleral fixation of a subluxated posterior chamber (PC) intraocular lens (IOL) using the snare technique with Gore-Tex suture from 2019 to 2021. Functional outcome was analysed by clinical...
Results of vitrectomy in epiretinal membranes secondary to retinal vein occlusions
This retrospective, observational multicentre study investigated the anatomic and functional results of vitrectomy associated with the peeling of secondary epiretinal membranes (ERM) in patients with retinal vein occlusion (RVO) and determined the prognostic factors of surgical outcomes. Data was collected...
Changes in ocular biomarkers in Vogt-Koyanagi-Harada disease after pulse steroid therapy
This retrospective study aimed to evaluate the early and chronological changes in ocular biomarkers in patients of Vogt Koyanagi Harada (VKH) disease who received pulse steroid therapy. It further aimed to identify which biomarkers correlated with the best corrected visual...BVI brings Finevision to the forefront of the refractive community at London event
Damien Gatinel, Head of The Anterior and Refractive Surgery, Paris, and Amir Hamid, Consultant Ophthalmic Surgeon, London addressed an audience at the Finevision event sponsored by BVI at No 11 Cavendish Square, London on 13 October 2023.Oertli Instrumente AG achieves milestone with FDA 510(k) clearance for Faros surgical system
Oertli Instrumente AG, a leader in innovative surgical solutions for ophthalmology, is proud to announce the U.S. Food and Drug Administration (FDA) 510(k) clearance for the worldwide established Faros anterior cataract surgery system. This milestone underscores Oertli's global reach and...Haag-Streit UK relaunches the Perkins Mk 3 hand-held applanation tonometer
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce that they have relaunched the Perkins Mk 3 hand-held applanation tonometer. Haag-Streit UK discontinued the...Oertli launches the OS 4 UpTM surgical platform along with new instruments for retina and cataract surgery
Berneck, 4th September 2025 – Oertli Instrumente AG presented its surgical platform, the OS 4 UpTM, to the attendees of the Euretina and ESCRS congresses. The platform introduces forward-thinking solutions for vitreoretinal and cataract surgery and is complemented by new...
Comparison of the efficacy of anti-VEGFs agents in nvAMD
This retrospective multicentric study conducted in Israel and Canada, compared the efficacy of bevacizumab, aflibercept 2mg and ranibizumab as first-line treatments for neovascular age-related macular degeneration (nvAMD). Included were treatment-naïve nvAMD eyes receiving ≥12 months of treat-and-extend (T&E) anti-VEGF therapy...Optical sector bodies unite on key principles for GOC registrant fee review
Leading optical sector organisations highlight strong alignment in response to GOC consultation on registrant fees Three leading optical sector organisations have written jointly to the General Optical Council (GOC) to highlight significant areas of agreement emerging from their respective responses...
